Tempus AI (TEM) Expected to Announce Quarterly Earnings on Tuesday

Tempus AI (NASDAQ:TEM) is expected to announce its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $328.8910 million for the quarter. Tempus AI has set its FY 2025 guidance at EPS.Parties may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 4:30 PM ET.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.Tempus AI’s quarterly revenue was up 89.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($6.86) earnings per share. On average, analysts expect Tempus AI to post $-6 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Tempus AI Trading Up 2.6%

TEM opened at $91.58 on Tuesday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The stock’s fifty day moving average is $84.46 and its two-hundred day moving average is $68.38. The company has a market capitalization of $15.91 billion, a P/E ratio of -76.96 and a beta of 4.87. Tempus AI has a 52 week low of $31.36 and a 52 week high of $104.32.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on TEM shares. BTIG Research raised their price target on Tempus AI from $85.00 to $96.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. TD Cowen cut shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 target price on the stock. in a report on Tuesday, October 21st. Piper Sandler raised their target price on shares of Tempus AI from $70.00 to $105.00 and gave the company a “neutral” rating in a research report on Wednesday, October 22nd. HC Wainwright upped their price target on shares of Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research report on Friday, September 12th. Finally, Canaccord Genuity Group initiated coverage on shares of Tempus AI in a research note on Monday, October 20th. They set a “buy” rating and a $110.00 price objective on the stock. Seven investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of “Hold” and a consensus target price of $79.38.

Insiders Place Their Bets

In other news, COO Ryan Fukushima sold 5,000 shares of Tempus AI stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $92.32, for a total value of $461,600.00. Following the transaction, the chief operating officer owned 130,000 shares of the company’s stock, valued at $12,001,600. The trade was a 3.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO James William Rogers sold 7,528 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $561,965.20. Following the transaction, the chief financial officer owned 138,473 shares of the company’s stock, valued at approximately $10,337,009.45. This trade represents a 5.16% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 767,412 shares of company stock worth $57,618,856. Insiders own 26.27% of the company’s stock.

Institutional Trading of Tempus AI

A number of institutional investors have recently made changes to their positions in the business. Pitcairn Co. purchased a new position in Tempus AI during the 2nd quarter worth $317,000. Nomura Holdings Inc. boosted its holdings in Tempus AI by 116.6% in the second quarter. Nomura Holdings Inc. now owns 45,860 shares of the company’s stock worth $2,914,000 after acquiring an additional 24,689 shares in the last quarter. FORA Capital LLC acquired a new stake in Tempus AI in the second quarter worth about $1,434,000. Tower Research Capital LLC TRC grew its stake in shares of Tempus AI by 15.7% during the second quarter. Tower Research Capital LLC TRC now owns 22,670 shares of the company’s stock worth $1,440,000 after acquiring an additional 3,072 shares during the last quarter. Finally, Sugar Maple Asset Management LLC acquired a new position in shares of Tempus AI during the second quarter valued at about $286,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.